Multivariate analysis demonstrated the involvement of only UGT1A1*6/*28 and *6/*6 as a risk factor for the occurrence of G4 neutropenia in patients with gynecological cancers who received low-dose CPT-11. This evidence concerns the gene UGT1A1 and female reproductive organ cancer.